Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Research Site, Brussels

Research Site, Vienna

Research Site, Vienna

Research Site, Brussels

Research Site, Antwerp

Research Site, Westmead

Research Site, Wilrijk

Research Site, Leuven

Research Site, Melbourne (Coburg)

Research Site, Mont-Godinne

Research Site, Hackensack

Research Site, Graz

Research Site, Roeselare

University of Florida/Pulmonary, Critical Care & Sleep Medicine, Gainesville

University of Miami Miller School of Medicine, Miami

Research Site, Pessac

Research Site, Montpellier

Research Site, Tours

Vanderbilt University Medical Center-IPF Program, Nashville

Research Site, Detroit

Research Site, Lille

Research Site, Chicago

University of Chicago, Chicago

Research Site, Strasbourg

Research Site, Pierre-Bénite

Research Site, Paris

Research Site, Seattle

Dartmouth-Hitchcock Medical Center, Lebanon

Research Site, Ottawa

Research Site, Bialystok

Research Site, Gdansk

Research Site, Lodz

Research Site, Exeter

Research Site, Plymouth

Research Site, London

Research Site, Bath, Avon